leisure time -WSS

leisure time

author：leisure time 2025-08-25 07:27:27 - browse：93569

Pfizer is this year’s anti-Eli Lilly. If David Ricks is the best biopharma CEO of 2023, then Pfizer CEO Albert Bourlais, unfortunately, the worst.

My annual Worst Biopharma CEO list is typically populated with blockheads and scoundrels. That’s not why Bourla is here. The reason is accountability. Strategic missteps, financial miscalculations, and scientific setbacks have plunged Pfizer into a deep crisis. Bourla is the man at the top, so the responsibility lies with him.

Pfizer shares have fallen 50% this year to their lowest level in more than a decade, erasing nearly $140 billion in market value. In 2022, the company delivered $100 billion in revenue, boosted by a widely used Covid vaccine and Covid treatment. This year, Covid product sales evaporated — and will fall further next year — leaving a vacuum Pfizer is struggling to fill with aging medicines nearing the end of their patent lives, and newer drugs and vaccines that have not performed as expected.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Heart attack and stroke risk calculators need revising
Next article： Data don't support strong claims for Covid

WSS

Sutter Health’s antitrust win overturned by appeals court

Take antibiotics after sex, CDC recommends for certain risk groups

For pregnant people, addiction treatment shouldn't mean a call to child protective services

Data don't support strong claims for Covid

Live blog: Hearing on CRISPR

Novartis is flashing warning signs about its newly acquired myelofibrosis drug

Wikipedia

leisure time

explore

Tori Bowie and the unacceptable rates of Black maternal death

Coloradans with cystic fibrosis could lose access to Trikafta

The cancer drug shortage isn’t new — and neither are the solutions

Bill would allow buprenorphine prescription for addiction via telehealth

Medicare details structure of new drug price negotiation program

Lung cancer screening guidelines updated for cigarette smokers

Jerome Adams on the need for new antivirals for Covid

Medicare must police algorithms in Medicare Advantage, Dems say

Anesthesiologist group: stop taking Ozempic before surgery

Structure Therapeutics oral GLP

hotspot

STAT wants to know your pick for a great summer read or listen

Prime Medicine says its gene editing passes test in monkeys

Readout LOUD podcast: ESMO highlights & Roivant's big deal

CMS got Medicare Advantage quality rating wrong, judge rules

Readout Newsletter: Medeor's stem cell study, Moderna's stock dip

The health care issue Democrats can’t solve: hospital reform

Wikipedia

knowledge

focus

knowledge